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Venomous animals are a significant health problem for rural populations in many parts of the world. Given the current level
of the international mobility of individuals and the inquisitiveness of travelers, clinicians and travel clinics need to be able
to give advice on the prevention, first aid, and clinical management of envenoming. Health professionals often feel over-
whelmed by the taxonomy of venomous animals; however, venomous animals can be grouped, using a simple set of criteria,
into cnidarians, venomous fish, sea snakes, scorpions, spiders, hymenoterans, and venomous terrestrial snakes. Geographic
distribution, habitats, and circumstances of accidents further reduce the range of culprits that need to be considered in any
single event. Clinical management of envenomed patients relies on supportive therapy and, if available, specific antivenoms.
Supplies of life-saving antivenoms are scarce, and this scarcity particularly affects rural populations in resource-poor settings.
Travel clinics and hospitals in highly industrialized areas predominantly see patients with injuries caused by accidents involving
marine animals: in particular, stings by venomous fish and skin damage caused by jellyfish. However, globally, terrestrial
venomous snakes are the most important group of venomous animals.
The medically important venomous animals consist of 6 major
groups: cnidarians, venomous fish, sea snakes, scorpions, spi-
ders, hymenopterans, and venomous terrestrial snakes. An an-
imal is classified as venomous if it possesses a special apparatus
for injecting venom. Toxic liquids delivered through special
teeth, stings, arrows, nematocysts, or hairs are used to fulfill
essential biological needs, such as self defense or catching prey.
Unlike venomous animals, animals classified as poisonous lack
an injection device. Rather, they possess toxins that are dis-
persed in their body tissues and that are activated when the
animal is ingested [1–5].
SOURCES OF INFORMATION
Our detailed, regularly updated database of the biology, epi-
demiology, prevention, first aid, and supportive and specific
antivenom treatment of animal envenoming and poisoning
formed the basis of this review. Personal contacts contributed
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substantially to our database, because most clinical experience
is gathered in remote areas and is not published.
DIVERSITY AND CLASSIFICATION OF
VENOMOUS AND POISONOUS ANIMALS
To assist clinicians in assessing envenomed patients, it is im-
portant to provide a classification system that takes into con-
sideration a clinician’s limited knowledge of the biology and
taxonomy of venomous and poisonous animals and the fact
that, in most instances, the culprit has not been reliably ob-
served by patients and bystanders and is not available for iden-
tification. Geographic distribution, habitat, behavior, and evolv-
ing clinical features help to delineate the culprit in the absence
of direct evidence. These efforts are guided by a central ques-
tion: is a venom implicated for which a specific antivenom is
available?
Grouping venomous animals using a simple set of criteria
(figure 1) substantially reduces the number of species that
have to be considered in an envenoming incident. Subdividing
venomous snakes—by far the largest and clinically most im-
portant group—into regional groups further reduces the
number of species to be considered in an individual case
(table 1).
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Figure 1. Grouping venomous and poisonous animals with a simple set of criteria
VENOMS, POISONS, AND THEIR CLINICAL
EFFECTS
Venoms are complex mixtures of species, subspecies, or even
geographic-variant–specific substances that are pharmacologi-
cally highly active and can cause a wide range of clinical signs
and symptoms. Venom effects are predominantly species-spe-
cific, which makes it difficult to transfer observations from
animals to humans. The wide range of signs and symptoms of
envenoming in humans are grouped into 7 classes: local, au-
topharmacological, antihemostatic, neurological, muscular, car-
diac, and renal effects.
MEDICALLY IMPORTANT VENOMOUS
ANIMALS
Cnidarians
Biology. A large number of coelenterate species (e.g., jellyfish,
anemones, and corals) use highly efficient venom application
devices—so-called nematocysts—for hunting and self-defense.
When contact is made with trigger hairs, nematocysts explode
and send out harpoons that penetrate the surface of the attacked
organism, tracking venom-filled tubes into tissue, wherein the
venom is released [4, 5].
Clinical features. Corals, anemones, and most jellyfish
cause local irritation of the skin (e.g., burning sensations and
erythema). Many tourists to the Mediterranean Sea experience
this when they are stung by the jellyfish Pelagia noctiluca (figure
2A–2C) [6]. Episodes of flare-up reactions can also occur (fig-
ure 2C) [7, 8]. A number of jellyfish species, however, induce
systemic envenoming in addition to producing massive local
effects on the skin, including necrosis (figure 2D, F, and G).
Such accidents have been reported in the Pacific Ocean and
the Caribbean Sea (caused by box jellyfishes) and in the Atlantic
and Indopacific oceans (caused by the Portuguese man o’ war).
Since systematic reporting was initiated in Australia in the first
half of the 20th century, ∼70 deaths have been attributed to
the sea wasp Chironex fleckeri alone (figure 2F) after experi-
encing a massive nematocyst discharge, death of the individual
may ensue within minutes. In tropical Australia, the Irukandji
(Carukia barnesi), a box jellyfish the size of a human thumb
(figure 2H), causes the Irukandji syndrome, which is accom-
panied by catecholamine release. Persons who experience sea-
bathers’ eruption (caused by sea lice [Linuche unguiculata]) pre-
sent to clinics with features that can be puzzling to those who
have never come across such skin eruptions (figure 2, E). All
cnidarians may cause type I hypersensitivity reactions after re-
peated exposure, which includes anaphylactic shock [4, 5, 9–13].
Prevention and first aid. Where dangerous jellyfish are sus-
pected, one should never swim or dive unprotected; so-called
stinger suits are fully protective. Universally effective and safe
first aid measures for the treatment of jellyfish stings are not
available. However, vinegar has been found to be very effective
in deactivating the nematocysts of box jellyfish and is widely
recommended and used in Australia [14], where it is available
in containers at beaches. However, vinegar is ineffective against
stings by the Pacific Portuguese man o’ war, and it can even
activate the nematocysts of the Atlantic variety of the same
genus. The rapid onset and severe course of envenoming poses
almost unsolvable problems in providing timely life-saving sup-
port in the event of an encounter with dangerous jellyfish.
Paramedical workers have been trained to apply antivenom on
site.
Clinical management. Patients with local envenoming re-
quire pain control and wound management, including tetanus
prophylaxis if the skin is broken. In the case of severe systemic
envenoming, treatment is mostly symptomatic, aiming to main-
tain respiration and blood circulation. Respiratory support and
cardiac massage should never be stopped prematurely, because
the toxins in jellyfish venom are heat labile; in fact, good out-
comes have been reported after prolonged periods of resusci-
tation. Specific antivenom is available only for individuals who
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Figure 2. A, “Print” of Pelagia noctiluca; B, Pelagia noctiluca specimen;
C, flare-up reaction of a Pelagia noctiluca print 10 days after the primary
contact; D, print from a Physalia physalis tentacle; E, print of sea lice
(Linuche unguiculata) at the contact area under the swimming suit. Eco-
logical, morphological, and clinical features of dangerous jellyfish: Chi-
ronex fleckeri may reach a bell diameter of 20 cm, and prefers shallow
coastal waters. Tentacle prints show the typical ladder pattern for this
animal (F). Physalia species—in fact, not a single individual, but a colony
of symbiotic polyps—floats on the water surface with the help of a gas-
filled bladder and produces whip-like tentacle prints (G). Carukia barnesi
(Irukandji), a pelagic box jellyfish, is the size of a human thumb. After
heavy storms it may be found in the inward zone of a reef. The nema-
tocysts of the bell produce a faint print on the skin (H).
have been envenomed by the box jellyfish Chironex fleckeri [15];
however, only this antivenom’s effect on pain and possibly on
skin damage is of proven value. Calcium antagonists (e.g., ver-
apamil) are no longer recommended as treatment.
Venomous Fish
Biology. Venomous fish carry venom-gland–bearing fin rays
for self defense. The venom glands are located mainly in the
dorsal fins, but they can also be found in the ventral and anal
fins (as observed in scorpion fish, lion fish, and stone fish,
which are marine animals) or in the dorsal and pectoral fin
(in catfish—mostly freshwater species). Stingrays have 1 or
more serrated stings, located on their whip-like tails, that may
exceed 30 cm in length. Freshwater stingrays (Potamotrygon
species) are found in rivers and lakes in South America and
Africa. Weever fish (of the Mediterranean and Eastern Atlantic
coastal waters) and toad fish possess venomous stings on their
gill covers and in the dorsal fins (figure 3).
In many species, the venom apparatus seems to have evolved
along with a sedentary life style in shallow waters for use as
protection from enemies attacking from above. While wading
in shallow waters, bathers can be stung in the foot, ankle, or
calf. Divers are at risk of stings from slowly swimming lion
fish, which may suddenly attack if disturbed. In fish markets
and when preparing venomous fish for consumption, handlers
must be vigilant because stings remain dangerous: the venom
continues to be active after the fish has been killed [3, 5].
Clinical features. Stings from venomous fish cause ago-
nizing pain. Mechanical injury destroys tissue, which is fol-
lowed by further damage caused by the local effect of the in-
jected venom. In rare instances, deeply penetrating stings can
affect large blood vessels and major nerves. Some species of
venomous fish can cause systemic envenoming [3, 4, 16, 17].
Prevention and first aid. Careful observation of the bottom
of shallow waters, swimming (instead of wading), and avoiding
free-swimming venomous fish are the most important preven-
tive measures. Because panicking as a result of severe pain and
the systemic effects of venom increases the risk of drowning,
victims must be brought ashore as quickly as possible. Im-
mersing the stung limb in hot water (!45C) is an effective
first aid measure [3, 4].
Clinical management. Pain control, wound management,
and tetanus prophylaxis are essential. Whenever possible, a local
nerve block with an anaesthetic is most effective. Mechanical
injury, remaining fragments of spines, and tissue damage caused
by injected venom may require surgery. Secondary bacterial
infections (e.g., with Vibrio species or Pseudomonas species) are
common and require special antibiotic recommendations. An-
tivenom is available only for stone fish envenoming; although
its efficacy has never been formally evaluated, marked pain relief
has been demonstrated in case series [3, 4, 16–18].
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Figure 3. Weeverfish (Trachinus species), found in the Mediterranean
Sea. Venomous spines are located on the dorsal fin (A) and the gill cover
(B).
Sea Snakes
Biology. Some 50 species of sea snakes form a specialized
snake family that is now classified as Elapidae. With the ex-
ception of 2 species, Hydrophis semperi and Laticauda crockeri,
all sea snakes live in the marine environment; however, some
may enter the mouths of rivers. Pelamis platurus is a pelagic
species that drifts across the Indian and Pacific Ocean, carried
over large distances by currents. All other species are found in
coastal waters; the beaked sea snake (Enhydrina schistosa) and
the annulated sea snake (Hydrophis cyanocinctus) are the 2 most
prominent species. Sea snakes are mainly a hazard to fishermen
in the subtropics and tropics, who are bitten when emptying
fishing nets or when wading in shallow, muddy waters [5, 19].
Clinical features. Rhabdomyolysis is the main feature of
envenoming by sea snakes. Early clinical signs are muscular
pain and tenderness followed by placid paralysis and renal fail-
ure. In nearly all cases there are no local warning signs of venom
injection; bite marks are virtually invisible. Well-documented
case series have been published on E. schistosa bites [19]. Single
case reports of Astrotia stokesi bites suggest neurotoxic modes
of action of the venom of this species [4].
Prevention and first aid. As with venomous fish, wading
in shallow, muddy waters and handling snakes—including dead
ones—should be avoided. Pressure immobilization is recom-
mended and is supported by several case reports [4, 19].
Clinical management. Administration of antivenom is in-
dicated as soon as signs and symptoms of systemic envenoming
become obvious. Dialysis and respiratory support are important
supportive measures [4, 19].
Scorpions
Biology. Scorpions inflict painful stings when squeezed or
handled. Most medically important species belong to the family
Buthidae; as a rule of thumb, these animals possess more slender
pincers than their less dangerous relatives. Systemic enven-
oming is caused by members of the genera Centruroides (found
in the Southwest region of the United States and in Mexico);
Tityus (in Brazil and Trinidad); Androctonus, Buthus, Leiurus,
and Nebo (in North Africa and the Near and Middle East);
Hemiscorpius (in Iran, Iraq, and Baluchistan); Parabuthus (in
South Africa); and Mesobuthus (on the Indian subcontinent).
Scorpions are nocturnal arthropods that live in or near houses;
most encounters between these animals and humans happen
here. Travelers are stung when they accidentally squeeze scor-
pions that are hiding in beds, luggage, shoes, and clothing [20].
Clinical features. Local envenoming causes pain, ery-
thema, and swelling. Systemic envenoming usually develops in
2 stages: a cholinergic phase involving vomiting, sweating, hy-
persalivation, priapism, bradycardia, and arterial hypotension,
followed by an adrenergic phase involving arterial hypertension,
tachycardia, and cardiac failure. Cranial nerves and neuro-
muscular junctions may also be affected. Respiratory failure
can precipitate and is multifactorial, including bronchial hy-
persecretion [21–25].
Prevention and first aid. Checking shoes, clothing, lug-
gage, and beds for scorpions is the most important individual
preventive measure, and sealing holes and cracks in walls of
houses reduces hiding places. First aid measures, such as splint-
ing of the affected limb and crepe bandages, have never been
systematically tested.
Clinical management. Local pain is controlled with local
anaesthetics and regional anaesthesia. Wound management and
tetanus prophylaxis are important. Treatment preferences of
systemically envenomed patients vary widely. Control of the
effects of an overstimulated autonomous nervous system with
a-blockers (e.g., prazosin), calcium-channel blockers (e.g., ni-
fedipine) and ACE inhibitors (e.g., captopril) has been suc-
cessfully achieved in Israel and India. In Saudi Arabia and the
Americas, the use of antivenoms is regarded as an equally im-
portant component of treatment [21–28].
Spiders
Biology and clinical features. Spiders employ venom jaws
that are connected to venom glands to catch prey and for use
in self defense. Few species are medically important; most spi-
ders either have venom jaws that are too small to penetrate
human skin or their venom is too weak to produce substantial
envenoming.
Spider bites may go unnoticed until clinical signs and symp-
toms develop, which may be confined to local erythematous
edema. Brown recluse spiders cause necrotic lesions around the
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bite site that are known as “necrotic araneism”: local edema
and ischaemia at the bite site are early features, which develop
into frank necrosis (eschar) within days and occasionally de-
velop into extended necrotic areas over weeks. South American
bird spiders (“tarantulas”) can, when disturbed, rub off urti-
cating hairs from their abdomens with their hind legs. Systemic
neurotoxic envenoming is caused by widow spiders (Latrodectus
species, common between latitudes 50N and 45S), wandering
spiders (Phoneutria species, found in South America), and fun-
nel web spiders (Atrax species and Hadronyche species, found
in southeast Australia) and resembles envenoming from scor-
pion stings. The clinical course of envenoming by these spiders
is also predominantly triggered by catecholamine release. Bra-
zilian ‘banana spiders’ (Phoneutria nigriventer) have been re-
ported to travel in bunches of bananas, causing bites and even
deaths in countries to which they are not native. Like scorpion
stings, spider bites occur in and around houses—in particular,
from spiders in the genera Latrodectus and Loxosceles. Outdoor
activities such as camping are also common settings for spider
bite incidents [2–4, [29]–34]. For prevention and first aid, the
same rules as for scorpion stings apply.
Clinical management. Local venom effects are either triv-
ial, only requiring routine wound management (including tet-
anus prophylaxis), or can cause severe problems because of
tissue necrosis around the bite site. Management of necrotic
araneism remains controversial. There are strong arguments for
routine wound management alone; however, published case
series of Loxosceles bites from Australia and South Africa in-
dicate that cases of systemic envenoming, especially those that
involve agonizing muscle spasms, respond well to antivenom
treatment. Funnel-web spider antivenom is equally beneficial
for patients who become envenomed by members of the Atrax
and Hadronyche genera [2–4, 29–34].
Hymenopterans (with a Focus on Bees, Wasps, and Ants)
Biology. Hymenopterans are insects that inject venom with a
stinging apparatus connected to venom glands in the terminal
part of the abdomen. Some species of ants lack a sting and,
instead, squirt their venom.
Honeybees and wasps are widely and numerously distributed
in cold and tropical climates; therefore, most humans experi-
ence multiple stings during a lifetime. Single stings are dangerous
for people who are allergic to the venom or if the site of the
sting is located in the throat. Envenoming in the true sense (i.e.,
experiencing the direct toxic effects of the venom) is rare and
requires hundreds or even thousands of stings in adults. Direct
toxic effects, as opposed to allergic reactions, account for !5%
of all deaths caused by hymenopteran stings [35].
Prevention and first aid. People who know that they are
allergic to hymenopteran venom should be advised to carry a
first aid kit and, most importantly, should be trained to inject
themselves with adrenaline (e.g., with an EpiPen). Hyposen-
sitization therapy should be offered to patients who have severe
allergic reactions. Bee stings should be removed as quickly as
possible, because they continue to pump venom into the tissues
even after they are separated from the body of the bee [35].
Clinical features. In nonallergic people and for single
stings, local toxic effects (including pain, redness, and swelling)
are the only clinical feature. Multiple stings induce extensive
swelling that can lead to hypovolemia and hemolysis, neuro-
logical disturbances, myolysis, and renal failure. The major
threats of hymenopteran stings are, however, hypersensitivity
reactions, which can be severe and life-threatening. The prev-
alence of honeybee and wasp venom allergies in the North
American population is 3.3% in adults and 0.8% in children.
Systemic signs and symptoms (e.g., flushing, tachycardia, ab-
dominal colic, or diarrhea) develop within a few minutes after
a sting. If left untreated, this can progress into hypotension,
coma, and death [35].
Clinical management. Adrenaline, steroids, and antihis-
tamines are the cornerstones to counteract the allergic effects
of hymenopteran venom. Most important and life-saving is
0.1% adrenaline (0.5–1.0 mL for adults, 0.01 mL/kg for chil-
dren), administered intramuscularly, for patients with sting
anaphylaxis. Local wound management and tetanus prophylaxis
should be performed if needed [35].
Venomous Terrestrial Snakes
An estimated 50,000–100,000 people die each year from snake
bites alone, and many more suffer from permanent disability
[36]. The rural populations of the tropics and subtropics suffer
most of all, because the habitats of snakes and humans overlap;
recreational travelers, however, rarely experience snake bites. In
a case report of a 21-year-old Swiss student in the Amazon
rainforest near Manaus, Brazil (figure 4), the student suddenly
felt a sharp pain in his right foot while walking with a friend
on an overgrown footpath in the evening. He was wearing open
sandals. After the pain occurred, he noticed something moving
away from the path through the vegetation. Later, he became
aware of 2 bleeding puncture wounds on his right foot. On the
way back to the camp he felt increasingly dizzy. The foot became
swollen and painful 1.5 h after the incident. Within an hour,
the swelling extended across the lower leg, up to the thigh, and
the lymph nodes in the groin became enlarged. Suspicion of a
snake bite as the most probable cause grew, and the 2 men
decided to set off to the nearest settlement (∼2 h away on foot).
After covering one-half of the distance, the pain became in-
tolerable and the student gave up. In despair, he photographed
the developments in the appearance of his right leg. His friend
carried on to seek help and returned after one-half of an hour
with a few men. They built a stretcher from wood and carried
the student to the nearest road leading out of the forest, where
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Figure 4. Photographs taken by a 21-year-old Swiss student docu-
menting the course of envenomation after being bitten by a snake on
his right foot (arrow) in the Amazon rainforest near Manaus, Brazil.
Photographs were taken 6.5 (A), 67 (B), and 96.5 (C) h after the bite.
a pick-up truck stopped and drove him to the hospital in
Manaus. Upon arrival, he had cross swelling of the entire right
leg and his blood was incoagulable. He received antivenom and
made a near-full recovery, with the exception of his right leg,
which over months continued to hurt and swell up when walking.
Biology. Venomous snakes have fangs located in the front
of the upper jaw that contain venom ducts that run along the
inside of the fangs. Venom is produced in specialized salivary
glands. In elapids (the Elapidae family), fangs are fixed and are
of small or moderate size. In vipers (viperids, of the family
Viperinae) and pit vipers (crotalids, of the family Crotalinae),
the fangs are mostly large and mobile. Pit vipers derive their
name from a heat-sensitive pit organ located between the eye
and the nostril that is used for orientation and, in particular,
for locating prey. Many species of the large colubrid family
(Colubridae) possess toxins in their salivary glands, which are
mounted at the base of the teeth in the hind part of the upper
jaw (table 1) [2–4, 37, 38].
Clinical features. The chemical makeups of snake venom,
which vary by species, subspecies, and even geographic variant
level, induce a wide range of clinical signs and symptoms. Sub-
division of symptoms into local, autopharmacological, anti-
hemostatic, neurological, muscular, cardiac, and renal effects
helps to stage the patient. In conjunction with information on
geographic distribution, habitat, and behavior of the snake, the
clinical pattern of signs and symptoms is useful to identify the
culprit. In some snake bites (those of crotalids, viperids, and
some cobras), but not in others (those of kraits, coral snakes,
and some Australasian elapids), local swelling indicates that
venom was injected, and absence of swelling reliably excludes
clinically relevant envenoming. A particular local problem is
chemical conjunctivitis and, in severe cases, corneal ulceration
and perforation caused by the venom emitted by spitting co-
bras. Autopharmacological effects of snake bites can lead to
extravasation of circulating fluid and hypovolemic shock and
to clinical features that resemble true type I hypersensitivity
reactions—particularly in cases of evenomation by viperids and
crotalids. Incoagulable blood and bleeding are common in pa-
tients who have been envenomed by viperids, crotalids, Aus-
tralasian elapids, and colubrids. In the case of envenomation
by viperids and crotalids, blood coagulation is additionally
compromised by toxin-induced disruption of the capillary en-
dothelium. Paralysis, which eventually also affects respiratory
muscles, is caused by the venom of elapids, Australasian elapids,
and very few crotalid and viperid species. Rhabdomyolysis oc-
curs from the bites of very few viperid, crotalid, Australasian
elapid species, and sea snakes. Acute renal failure is mostly
caused by hypotension and shock [2–4, 37–39].
Prevention and first aid. Boots and long, heavy trousers
are essential to avoid snake bites. Carrying a torch at night is
useful, as is stepping hard on the ground when walking (because
snakes are sensitive to vibration). Sleeping on the ground with-
out a sewn-in ground sheet should be avoided; camp beds are
recommended. Bed nets are also protective.
There is no universally applicable method to reliably delay the
transport of venom from the bite site into systemic circulation
without causing damage. Tourniquets cause severe tissue destruc-
tion, depending on the pressure exerted. Cut and suction devices
(e.g., “venom-ex”) designed to remove venom from the local
tissues are not only entirely ineffective, but are also dangerous.
The same applies to electric shocks, instillation of chemical com-
pounds, cryotherapy, and “snake stones.” Instead, calming and
immobilizing the patient (i.e., by splinting bitten limbs and car-
rying patients) after an accident are crucial. More effective is the
application of a crepe bandage to compress lymphatic vessels,
thereby impeding systemic spread. Correct application of crepe
bandages, however, poses many practical problems, including the
application of the recommended pressure of 55 mm Hg. Ex-
perimentally, this method has been studied in Australia; its
clinical efficacy, however, has never been validated. In regions
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wherein snakes cause local envenoming, crepe bandages may
give rise to severe adverse effects [2–4, 37–39].
Clinical management. Clinical management of snake bites
ideally relies on both symptomatic supportive treatment and
specific antivenom therapy. Because most accidents happen in
remote areas that have limited resources, remedies are in short
supply or may not be available at all. This is especially true for
antivenoms, which, worldwide, are in very short supply, are
frequently of poor quality, and are very expensive. For decades,
pleas have been made to national and international bodies to
speed antivenom development and to increase production and
distribution of these life-saving remedies, without much, if any,
success [40–42]. Indications for antivenom use are the signs
and symptoms of systemic envenoming: (1) hypotension or
other signs and symptoms of autopharmacological reactions,
(2) hemostatic abnormalities or spontaneous systemic bleeding,
(3) paralysis, (4) rhabdomyolysis, (5) cardiovascular signs and
symptoms, and (6) renal impairment. In local envenoming,
antivenom is indicated if (1) the species that has inflicted the
bite is known to cause local necrosis; (2) there is swelling that
involves more than one-half of the bitten limb; (3) there is
rapidly progressive swelling; and (4) there are bites on the
fingers or toes [2–4, 37–40]. One has to be well aware that
signs and symptoms of envenoming can be very much delayed,
thereby necessitating the observation of patients 24 h after a
bite. Depending on the antivenom available (monospecific, po-
lyspecific), the culprit has to be identified to a (sub)species or
even geographic variant level, a process that can be complicated
by the whole range of problems mentioned above. The quality
of antivenoms—namely, their severe adverse effects in approx-
imately one-half of the patients to whom crude antivenoms are
administered—makes monitoring and treatment of side effects
an important part of managing envenomed patients. Pretesting
for allergic reactions is unreliable [43]. Premedication with sub-
cutaneous adrenaline has shown some effect in 1 study [44].
Repeated doses of antivenom are often required because of
prolonged absorption of venom from the bite site. In travel
clinics, the question is often asked whether antivenoms should
be carried along when traveling in remote areas in which snake
bites are a problem. As a rule, the answer is “no,” because the
decision to give antivenom, its application, and the manage-
ment of adverse effects requires medical skills and appropriate
equipment.
In addition to antivenom treatment, supportive medical care
(e.g., respiratory support and renal replacement therapy) is reg-
ularly needed in the event of a snake bite. Incoagulable blood
and consecutive hemorrhage must be diagnosed early to initiate
and repeat antivenom therapy, if needed. For this purpose, the
20-minute whole-blood clotting test is a simple and adequate
bedside test to assess blood coagulability. Treatment of local tissue
damage around the bite site ranges from simple wound man-
agement to debridement for extensive necrosis [2–4, 37–39].
Because bacteria can be introduced by the fangs of the snake
and can cause subsequent wound infection, including abcesses,
tetanus prophylaxis must be boosted. Wounds should be fol-
lowed-up and antibiotics should be given when indicated; how-
ever, antibiotic prophylaxis does not seem to be of advantage
[45–47]. Compartment syndrome is rare and should be diag-
nosed only after measuring compartment pressure [2–4, 37–39].
CONCLUSIONS
Accidents caused by encounters with venomous animals are
some of the most neglected health threats affecting predomi-
nately poor rural communities. International attention and re-
sponse is needed to ameliorate this problem [41, 42]. Although
travelers rarely face life-threatening accidents, morbidity—par-
ticularly caused by venomous marine animals—is of impor-
tance in this group. Given the current level of international
mobility of individuals, clinicians and travel clinics need to be
able to give advice on the prevention, first aid, and clinical
management of envenoming.
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